1
|
Vijaya Bharathi D, Hotha KK, Kolagatla PRR, Venkateswarlu V. Low dose aspirin estimation: an application to a human pharmacokinetic study. Biomed Chromatogr 2012; 27:589-98. [DOI: 10.1002/bmc.2832] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2012] [Accepted: 09/19/2012] [Indexed: 11/05/2022]
Affiliation(s)
- D. Vijaya Bharathi
- Bioanalytical Department, Integrated Product Development; Dr Reddy's Laboratories Ltd, Bachupalli; Hyderabad-500 072; India
| | - Kishore Kumar Hotha
- Bioanalytical Department, Integrated Product Development; Dr Reddy's Laboratories Ltd, Bachupalli; Hyderabad-500 072; India
| | - Pandu Ranga Reddy Kolagatla
- Bioanalytical Department, Integrated Product Development; Dr Reddy's Laboratories Ltd, Bachupalli; Hyderabad-500 072; India
| | - V. Venkateswarlu
- Bioanalytical Department, Integrated Product Development; Dr Reddy's Laboratories Ltd, Bachupalli; Hyderabad-500 072; India
| |
Collapse
|
2
|
Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1. Pharmacogenet Genomics 2012; 22:525-37. [PMID: 22513397 DOI: 10.1097/fpc.0b013e32835366f6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
OBJECTIVES Aspirin (ASA), a major antiplatelet and cancer-preventing drug, irreversibly blocks the cyclooxygenase (COX) activity of prostaglandin H synthase-1 (PGHS-1). Considerable differences in ASA effectiveness are observed between individuals, and some of this variability may be due to PGHS-1 protein variants. Our overall aim is to determine which, if any, of the known variants in the mature PGHS-1 protein lead to functional alterations in COX catalysis or inhibition by ASA. The present study targeted four PGHS-1 variants: R53H, R108Q, L237M, and V481I. METHODS Wild-type human PGHS-1 and the four polymorphic variants were expressed as histidine-tagged, homodimeric proteins in insect cells using baculovirus vectors, solubilized with a detergent, and purified by affinity chromatography. The purified proteins were characterized in vitro to evaluate COX and peroxidase (POX) catalytic parameters and the kinetics of COX inhibition by ASA and NS-398. RESULTS Compared with the wild type, several variants showed a higher COX/POX ratio (up to 1.5-fold, for R108Q), an elevated arachidonate Km (up to 1.9-fold, for R108Q), and/or a lower ASA reactivity (up to 60% less, for R108Q). The decreased ASA reactivity in R108Q reflected both a 70% increase in the Ki for ASA and a 30% decrease in the rate constant for acetyl group transfer to the protein. Computational modeling of the brief ASA pulses experienced by PGHS-1 in circulating platelets during daily ASA dosing predicted that the 60% lower ASA reactivity in R108Q yields a 15-fold increase in surviving COX activity; smaller, approximately two-fold increases in surviving COX activity were predicted for L237M and V481I. NS-398 competitively inhibited COX catalysis of the wild type (Ki=6 µmol/l) and inhibited COX inactivation by 1.0 mmol/l ASA in both the wild type (IC50=0.8 µmol/l) and R108Q (IC50=2.1 µmol/l). CONCLUSION Of the four PGHS-1 variants examined, R108Q exerts the largest functional effects, with evidence for impaired interactions with a COX substrate and inhibitors. As Arg108 is located on the protein surface and not in the active site, the effects of R108Q suggest a novel, unsuspected mechanism for the modulation of the PGHS-1 active site structure. The lower intrinsic ASA reactivity of R108Q, V481I, and L237M, combined with the rapid hydrolysis of ASA in the blood, suggests that these variants decrease the antiplatelet effectiveness of the drug. These PGHS-1 variants are uncommon but ASA is used widely; hence, a considerable number of individuals could be affected. Further examination of these and other PGHS-1 variants will be needed to determine whether PGHS-1 genotyping can be used to personalize anti-COX therapy.
Collapse
|
3
|
Murillo Pulgarín JA, Alañón Molina A, Sánchez-Ferrer Robles I. Simultaneous determination of salicylic acid and salicylamide in biological fluids. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2011; 79:909-914. [PMID: 21561802 DOI: 10.1016/j.saa.2011.03.047] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/09/2010] [Revised: 03/04/2011] [Accepted: 03/16/2011] [Indexed: 05/30/2023]
Abstract
A new methodology for the simultaneous determination of salicylic acid and salicylamide in biological fluids is proposed. The strong overlapping of the fluorescence spectra of both analytes makes impossible the conventional fluorimetric determination. For that reason, the use of fluorescence decay curves to resolve mixtures of analytes is proposed; this is a novel technique that provides the benefits in selectivity and sensitivity of the fluorescence decay curves. In order to assess the goodness of the proposed method, a prediction set of synthetic samples were analyzed obtaining recuperation percentages between 98.2 and 104.6%. Finally, a study of the detection limits was done using a new criterion resulting in values for the detection limits of 8.2 and 11.6 μg L(-1) for salicylic acid and salicylamide respectively. The validity of the method was tested in human serum and human urine spiked with aliquots of the analytes. Recoveries obtained were 96.2 and 94.5% for salicylic acid and salicylamide respectively.
Collapse
Affiliation(s)
- J A Murillo Pulgarín
- Department of Analytical Chemistry and Foods Technology, University Castilla-La Mancha, 13071 Ciudad Real, Spain.
| | | | | |
Collapse
|
4
|
Xu X, Koetzner L, Boulet J, Maselli H, Beyenhof J, Grover G. Rapid and sensitive determination of acetylsalicylic acid and salicylic acid in plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study. Biomed Chromatogr 2009; 23:973-9. [PMID: 19358313 DOI: 10.1002/bmc.1209] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
A simple and sensitive analytical method using liquid chromatography-tandem mass spectrometry (LC/MS/MS) for determination of acetylsalicylic acid (aspirin, ASA) and its major metabolite, salicylic acid (SA), in animal plasma has been developed and validated. Both ASA and SA in plasma samples containing potassium fluoride were extracted using acetonitrile (protein precipitation) with 0.1% formic acid in it. 6-Methoxysalicylic acid was used as the internal standard (IS). The compounds were separated on a reversed-phase column. The multiple reaction monitoring mode was used with ion transitions of m/z 178.9 --> 136.8, 137.0 --> 93.0 and 167.0 --> 123.0 for ASA, SA and IS, respectively. The lower limits of quantification for ASA and SA were 3 and 30 ng/mL, respectively. The developed method was successfully applied for the evaluation of pharmacokinetics of ASA and SA after p.o. and i.v. administration of 1 mg/kg to rats.
Collapse
Affiliation(s)
- Xiangrong Xu
- Eurofins/Product Safety Laboratories, 2394 US-130, Dayton, NJ 08810, USA.
| | | | | | | | | | | |
Collapse
|
5
|
Gadalla MAF, Ismail AA, Abd El-Hameed MH. In-Vivo Evaluation of Different Types of Commercial Aspirin Tablets. Drug Dev Ind Pharm 2008. [DOI: 10.3109/03639048909040223] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
6
|
Bae SK, Seo KA, Jung EJ, Kim HS, Yeo CW, Shon JH, Park KM, Liu KH, Shin JG. Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study of Astrix in Korean healthy volunteers. Biomed Chromatogr 2008; 22:590-5. [PMID: 18254152 DOI: 10.1002/bmc.973] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
The first liquid chromatography-tandem mass spectrometry (LC/MS/MS) method for determination of acetylsalicylic acid (aspirin, ASA) and one of its major metabolites, salicylic acid (SA), in human plasma using simvastatin as an internal standard has been developed and validated. For ASA analysis, a plasma sample containing potassium fluoride was extracted using a mixture of ethyl acetate and diethyl ether in the presence of 0.5% formic acid. SA, a major metabolite of ASA, was extracted from plasma using protein precipitation with acetonitrile. The compounds were separated on a reversed-phase column with an isocratic mobile phase consisting of acetonitrile and water containing 0.1% formic acid (8:2, v/v). The ion transitions recorded in multiple reaction monitoring mode were m/z 179 --> 137, 137 --> 93 and 435 --> 319 for ASA, SA and IS, respectively. The coefficient of variation of the assay precision was less than 9.3%, and the accuracy exceeded 86.5%. The lower limits of quantification for ASA and SA were 5 and 50 ng/mL, respectively. The developed assay method was successfully applied for the evaluation of pharmacokinetics of ASA and SA after single oral administration of Astrix (entero-coated pellet, 100 mg of aspirin) to 10 Korean healthy male volunteers.
Collapse
Affiliation(s)
- Soo Kyung Bae
- Department of Clinical Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, Korea
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Yamamoto E, Takakuwa S, Kato T, Asakawa N. Sensitive determination of aspirin and its metabolites in plasma by LC-UV using on-line solid-phase extraction with methylcellulose-immobilized anion-exchange restricted access media. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 846:132-8. [PMID: 16959551 DOI: 10.1016/j.jchromb.2006.08.037] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2006] [Revised: 08/05/2006] [Accepted: 08/22/2006] [Indexed: 11/23/2022]
Abstract
We describe a sensitive determination of aspirin (ASA) and its three metabolites (salicylic acid [SA], 2,3-dihydroxybenzoic acid [2,3-DHBA], and 2,5-dihydroxybenzoic acid [gentisic acid (GA)]) in rat plasma. Analysis was carried out by on-line solid-phase extraction (SPE) using a methylcellulose-immobilized-strong anion-exchanger (MC-SAX), followed by liquid chromatography (LC) coupled with UV detection. The lower limits of quantitation for ASA and SA were 60 ng/mL in 100 microL of plasma, respectively. This method was validated with respect to intra- and inter-day precision, accuracy, and linearity up to concentrations of 20,000 ng/mL for ASA, SA, 2,3-DHBA and gentisic acid, respectively. The method was successfully applied to an analysis of the pharmacokinetics of ASA and SA in rats.
Collapse
Affiliation(s)
- Eiichi Yamamoto
- Analytical Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
| | | | | | | |
Collapse
|
8
|
Berkovitch M, Uziel Y, Greenberg R, Chen-Levy Z, Arcusin M, Marcus O, Pinto O, Evans S, Matias A, Lahat E. False-high blood salicylate levels in neonates with hyperbilirubinemia. Ther Drug Monit 2000; 22:757-61. [PMID: 11128247 DOI: 10.1097/00007691-200012000-00018] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Drug assays may yield false-positive results caused by cross-reacting compounds. After finding a serum salicylate concentration of 81 microg/mL by using Trinder's colorimetric method, in a comatose child admitted to the authors' pediatric intensive care unit, in the absence of reported salicylate intake, the authors aimed to compare this situation with the phenomenon involving endogenous digoxin-like substances, which cross-react with the routine assay of digoxin. None of the participants in the study had been exposed to salicylate. Salicylate concentration was measured in all patients using Trinder's colorimetric method and in the second stage of the study also by AxSYM salicylate assay. Salicylate concentration using Trinder's method was 18 +/- 25 (4-81) microg/mL among nine seriously ill children in the pediatric intensive care unit, of whom two children with extensive burns had salicylate levels of 30 and 81 microg/mL, respectively. Salicylate concentrations were 107 +/- 24 (45-143) microg/mL and 60 +/- 25 (28-92) microg/mL, among 18 premature newborns and 18 term newborns, with hyperbilirubinemia, respectively. In the second stage, which involved 22 jaundiced term newborns and cord blood from 21 pregnant women, Trinder's method yielded elevated salicylate blood levels among the hyperbilirubinemic infants: 82 +/- 5 (73-89) microg/mL; however, the AxSYM assay yielded significantly lower blood levels: 2.5 +/- 3.4 (0-10.9) microg/mL (P < 0.0001). Among the pregnant women, salicylate cord blood levels were found to be low-within the limit error of the assay with both assay methods. In conclusion, when salicylate intoxication is suspected, particularly during the neonatal period, it is advisable to measure salicylate levels by immunoassay technology.
Collapse
Affiliation(s)
- M Berkovitch
- Department of Pediatrics, Assaf Harofeh Medical Center, Zerifin, Israel
| | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
FERREIRA VJF, CAVALHEIRO ACV, FAGNANI E, MORAES MD, PEZZA L, PEZZA HR, MELIOS CB. An Electrode of the Second Kind for Aspirin Determination in Tablet Formulations. ANAL SCI 1999. [DOI: 10.2116/analsci.15.249] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
10
|
Muir N, Nichols JD, Stillings MR, Sykes J. Comparative bioavailability of aspirin and paracetamol following single dose administration of soluble and plain tablets. Curr Med Res Opin 1997; 13:491-500. [PMID: 9169251 DOI: 10.1185/03007999709113322] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
In this study, the bioavailability of aspirin and paracetamol was compared in plain and soluble combination formulations in fasting, healthy volunteers. Blood samples were taken and Cmax, Tmax and AUC measured at various times following administration of single doses of the two formulations in 12 subjects. The rapidity of uptake of aspirin following administration of a soluble formulation suggests significant absorption from the stomach. There was no significant difference in the pharmacokinetic parameters of paracetamol derived from a soluble or plain formulation. A comparison of the uptake of aspirin from the soluble aspirin formulation with paracetamol from either plain or soluble tablets showed that aspirin entered the plasma and achieved peak levels significantly more quickly. However, the half life of paracetamol was significantly longer than that of aspirin. These findings suggest that onset of analgesia should be more rapid following dosing with soluble aspirin, a conclusion supported by comparative efficacy studies conducted with differing formulations of aspirin.
Collapse
Affiliation(s)
- N Muir
- Reckitt & Colman Plc, Hull, UK
| | | | | | | |
Collapse
|
11
|
Petersen JR, Bissell MG, Mohammad AA. Laser induced resonance energy transfer--a novel approach towards achieving high sensitivity in capillary electrophoresis. I. Clinical diagnostic application. J Chromatogr A 1996; 744:37-44. [PMID: 8843662 DOI: 10.1016/0021-9673(96)00435-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Most of the procedures currently performed by capillary zone electrophoresis (CZE) with laser induced fluorescence detection requires prior derivatization. This increases cost, the turn-around-time and chances of extraneous contaminations. CZE with laser induced resonance energy transfer is demonstrated as a viable alternative for detecting non-fluorescent compounds with no prior derivatization. The feasibility of this approach is demonstrated by separating and directly detecting salicylic acid (2,4-dihydroxybenzoic acid), gentisic acid (o-methoxybenzoic acid), salicyluric acid (o-hydroxyhippuric acid) and 4-aminosalicylic acid in urine. The detection of salicylate in serum is also shown. The method is highly sensitive with detection limits in the 1.10(-7) M range. Importantly it requires no prior preconcentration or sample preparation and can be used with complex sample matrices such as serum and urine.
Collapse
Affiliation(s)
- J R Petersen
- Department of Pathology, University of Texas-Medical Branch, Galveston 77555, USA
| | | | | |
Collapse
|
12
|
Restifo RJ, Dumanian GA, Garrett KO, Hong C, Johnson PC. Prostacyclin production at the human microvascular anastomosis: its effect on initial platelet deposition. Plast Reconstr Surg 1996; 97:784-91. [PMID: 8628773 DOI: 10.1097/00006534-199604000-00015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The human microvascular anastomosis represents a localized environment with strongly thrombotic tendencies. In previous studies, an increase in initial platelet deposition at a human ex vivo anastomosis was measured. It is postulated that this increase in anastomotic platelet deposition was due to a reduction in anastomotic prostacyclin production as a consequence of local endothelial cell injury or loss. Instead, in this study, an increase in anastomotic prostacyclin production over unsutured controls (control 1093 +/- 222 pg/ml of 6-keto prostaglandin F (PGF) 1-alpha, n=21; anastomosis 2494 +/- 414, n=21, mean +/- 1 SEM, p=0.005) is demonstrated. Anastomotic prostacyclin production was augmented by addition of arachidonic acid (0.1 mM) (39,000 +/- 11,300 pg/ml of 6-keto PGF 1-alpha, n=7, p<0.001) and suppressed by the preincubation of vessel segments with aspirin in a dose-dependent fashion (1mM) (83+/-22 pg/ml of 6-keto PGF 1-alpha, n=21, p<0.001); aspirin (0.1 mM) (312 +/- 56 pg/ml of 6-keto PGF 1-alpha, n=7, p<0.001). In further studies using a perfusion apparatus of human blood pumped through human placental artery segments, suppression of prostacyclin production did not augment initial platelet deposition (control anastomosis 4.9 +/- 2.2 x10(6) platelets per cm2, aspirin treatment 6.0 +/- 2.8 x 10(6) platelets per cm2, n=5, mean +/- 1 SEM, p>0.05). Suppression of platelet function with aspirin (0.1 mM) also did not decrease initial platelet deposition onto the anastomosis (5.8 +/- 2.8 x 10(6) platelets per cm2, n=r, p>0.05). In this model system, initial platelet deposition at the anastomosis may not be dependent upon cyclooxygenase pathways.
Collapse
|
13
|
Li YH, Ren ZH, Li XL, Cai YF, Zhai ZX. Determination of salicylic acid in plasma by gas chromatography using steam as carrier gas. Biomed Chromatogr 1995; 9:155-6. [PMID: 7655306 DOI: 10.1002/bmc.1130090310] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
A gas chromatography method using steam as the carrier gas was established for the determination of salicylic acid in plasma. A 0.5 mL plasma sample was mixed with 0.5 mL of 6N HCl and then extracted with 2 mL of dichloromethane. The dichloromethane was evaporated to dryness and the residue was redissolved in 0.5 mL of water and then analysed by gas chromatography using steam as the carrying gas. The result was calculated by external standardization.
Collapse
Affiliation(s)
- Y H Li
- College of Pharmacy, Second Military Medical University, Shanghai, People's Republic of China
| | | | | | | | | |
Collapse
|
14
|
Seymour RA, Weldon M, Kelly P, Nicholson E, Hawkesford JE. An evaluation of buffered aspirin and aspirin tablets in postoperative pain after third molar surgery. Br J Clin Pharmacol 1992; 33:395-9. [PMID: 1576068 PMCID: PMC1381328 DOI: 10.1111/j.1365-2125.1992.tb04057.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
1. Single doses (500 and 1000 mg) of both buffered aspirin and aspirin tablets were compared with placebo in a randomised double-blind trial of parallel design in patients with postoperative pain after third molar surgery. 2. Only buffered aspirin 500 mg provided significant pain relief (P = 0.016) during the 5 h investigation period. 3. A significant correlation (P = 0.004) was observed between overall pain scores after the various aspirin treatments and aspirin esterase activity. 4. Buffered aspirin preparations afforded a slight advantage over aspirin tablets in the control of postoperative pain after third molar surgery. However, the duration of analgesia was short (approximately 2 h). 5. Aspirin esterase activity appears to be an important determinant of the drug's efficacy in postoperative dental pain.
Collapse
Affiliation(s)
- R A Seymour
- Department of Operative Dentistry, Dental School, Newcastle upon Tyne
| | | | | | | | | |
Collapse
|
15
|
Holland IS, Seymour RA, Ward-Booth RP, Ord RA, Lim KL, Hoare RC. An evaluation of different doses of soluble aspirin and aspirin tablets in postoperative dental pain. Br J Clin Pharmacol 1988; 26:463-8. [PMID: 3190996 PMCID: PMC1386569 DOI: 10.1111/j.1365-2125.1988.tb03406.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
1. The efficacy of three different single doses (600, 900 and 1200 mg of soluble aspirin and aspirin tablets) was determined in a randomized placebo-controlled parallel study in 140 patients (70 females) with postoperative pain after removal of impacted third molars. 2. Patients treated with soluble aspirin 600 mg, 900 mg, 1200 mg and aspirin tablet 1200 mg reported significantly less pain (P less than 0.01) throughout the investigation period than those treated with placebo. 3. Overall pain scores after treatment with aspirin tablets 600 and 900 mg did not differ significantly from those after treatment with placebo (P greater than 0.05). 4. On a comparative dose basis, soluble aspirin was significantly more potent (P less than 0.05) than aspirin tablets.
Collapse
Affiliation(s)
- I S Holland
- Department of Oral and Maxillofacial Surgery, Sunderland District General Hospital
| | | | | | | | | | | |
Collapse
|
16
|
Koupparis MA, Anagnostopoulou PI. Automated flow injection determination of salicylates using Trinder reaction for clinical analysis, assays and dissolution studies of formulations. J Pharm Biomed Anal 1988; 6:35-46. [PMID: 16867438 DOI: 10.1016/0731-7085(88)80028-1] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/1986] [Revised: 07/08/1986] [Indexed: 10/17/2022]
Abstract
An automated flow-injection technique is described for salicylate (25-250 or 80-800 mg l(-1)), salicylamide (30-300 mg l(-1)), methylsalicylate (100-1000 mg l(-1)) and acetylsalicylic acid (after alkaline hydrolysis), based on their colour reaction with iron (III) in weak acid medium. The method was evaluated for the determination of salicylate in serum, the assay of the drugs in commercial formulations and automated dissolution studies of drug tablets. There were decreased interferences because of the short reaction time. The precision was good with RSD less than 1% in all cases. Recoveries of salicylate from spiked sera (100-1000 mg l(-1)) varied from 96.4-102.5% (mean 99.3%), and from spiked sample solutions of acetylsalicylic acid, 97.8-103.0% (mean 99.6%). The results of the analysis of commercial drug formulations obtained with the proposed method agreed well with the current USP and BP procedures, with differences of 0.4-1.5% (mean 0.8%). High measurement rates of 180 or 95 per hour were achieved using manifolds without and with predilution respectively.
Collapse
Affiliation(s)
- M A Koupparis
- University of Athens, Department of Chemistry, Laboratory of Analytical Chemistry, 104 Solonos str., Athens 106 80, Greece
| | | |
Collapse
|
17
|
Seymour RA, Williams FM, Luyk NM, Boyle MA, Whitfield PM, Nicholson E, Booth PW, Rawlins MD. Comparative efficacy of soluble aspirin and aspirin tablets in postoperative dental pain. Eur J Clin Pharmacol 1986; 30:495-8. [PMID: 3743627 DOI: 10.1007/bf00607968] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The efficacy of single doses (1.2 g) of soluble aspirin and aspirin tablets was determined in a randomised, placebo-controlled, double-blind, parallel study in 90 patients (45 females) with postoperative pain after removal of impacted lower third molars. Also investigated was the relationship between plasma aspirin esterase activity and overall pain scores after both aspirin preparations. Patients reported significantly less pain (p less than 0.001) after treatment with aspirin than after treatment with placebo. However, patients receiving soluble aspirin reported both an earlier onset and a longer duration of pain relief than those who received aspirin tablets. A significant correlation was observed between plasma aspirin esterase activity and overall pain scores after both soluble aspirin (r = 0.57, p less than 0.01) and aspirin tablets (r = 0.51, p less than 0.02). It is concluded that soluble aspirin is the preferred aspirin formulation for treating postoperative pain after third molar surgery and that plasma aspirin esterase activity is determinant of a patient's analgesic response to aspirin in postoperative dental pain.
Collapse
|
18
|
Nieder M, Jaeger H. Determination of acetylsalicylic acid and salicylic acid in blood and plasma by HPLC. ACTA ACUST UNITED AC 1983. [DOI: 10.1002/jhrc.1240061204] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
19
|
Bélanger PM, Lalande M, Doré F, Labrecque G. Rapid gas chromatographic determination of serum salicylates after silylation. J Pharm Sci 1983; 72:1092-3. [PMID: 6631703 DOI: 10.1002/jps.2600720935] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
20
|
Morris ME, Levy G. Determination of salicylamide and five metabolites in biological fluids by high-performance liquid chromatography. J Pharm Sci 1983; 72:612-7. [PMID: 6875820 DOI: 10.1002/jps.2600720609] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Two high-performance liquid chromatographic (HPLC) assay procedures were developed for the determination of salicylamide and its metabolites in serum, urine, and saliva. One method involves reverse-phase ion-pair chromatography and UV detection, and is used to determine salicylamide, salicylamide glucuronide, and salicylamide sulfate. The other method, with a different mobile phase and without the ion-pairing reagent, is used to determine gentisamide (the hydroxylated metabolite of salicylamide), gentisamide glucuronide, and gentisamide sulfate. The assays are performed by direct injection of the sample after protein precipitation with ethanol containing the internal standard. Increased sensitivity for the determination of low concentrations of salicylamide is obtained by organic extraction of this drug from serum or saliva. Calibration curves for the conjugates of salicylamide and gentisamide were obtained, in the absence of authentic standards, by partial enzymatic hydrolysis, using the decrease of the conjugate peaks and the concomitant increase of free salicylamide or gentisamide concentrations to determine peak area ratio-concentration relationships. Application of the HPLC assay procedures to the determination of salicylamide excretion products in the urine of three normal human subjects resulted in 98.6% (range:97.1-100.1%) recovery of a 1-g oral dose of the drug. All five metabolites of salicylamide were found in urine, but only salicylamide glucuronide, salicylamide sulfate, and gentisamide glucuronide were found consistently and in appreciable quantities. Salicylamide and all of its metabolites except gentisamide sulfate were found in human and rat serum, and unconjugated salicylamide as well as gentisamide were found in human saliva.
Collapse
|
21
|
Ingalls ST, Schwerkoske JF, Forman WB, Hoppel CL. Rapid and sensitive method for the determination of salicylic acid in serum by reversed-phase ion-pair high-performance liquid chromatography. JOURNAL OF CHROMATOGRAPHY 1983; 274:366-71. [PMID: 6874842 DOI: 10.1016/s0378-4347(00)84445-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
22
|
Petersen T, Husted SE, Pedersen AK, Geday E. Systemic availability of acetylsalicylic acid in human subjects after oral ingestion of three different formulations. ACTA PHARMACOLOGICA ET TOXICOLOGICA 1982; 51:285-91. [PMID: 7180498 DOI: 10.1111/j.1600-0773.1982.tb01028.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Systemic availability of acetylsalicylic acid (ASA) in normal human subjects after oral ingestion of 1 g in three different formulations was determined by using high-pressure liquid chromatography for ASA assay. For an effervescent, a plain and a sustained release preparation systemic availabilities expressed in percent of the ingested dose were 16.9 +/- 3.2, 8.6 +/- 1.2 and 2.6 +/- 0.4%, respectively. All subjects had clearly measureable amounts of ASA in plasma after oral intake of a sustained release preparation with an average peak concentration of 15 mumol/l. Peak concentration after an effervescent and plain formulation was on the average 80 and 40 mumol/l, respectively. Half-life of ASA in plasma was 18.1 +/- 1.2 min. for the effervescent and 28.7 +/- 5.3 min. for the plain preparation, while the elimination phase was too ill defined for the sustained release formulation. Average plasma half-life of salicylic acid (SA) was similar after the three different administration forms with values between 3.0 and 3.7 hrs. Further, no difference in SA distribution volumes or amounts of SA absorbed was found. The present study demonstrates that oral ingestion of ASA in effervescent, plain and sustained release formulations gives rise to significant amounts of ASA in plasma. Concentrations found indicate that long-term antithrombotic therapy with ASA in a sustained release formulation may be possible.
Collapse
|
23
|
Abstract
1 Soluble aspirin, 600 mg and 1200 mg, and placebo were compared in a double-blind, cross-over study in 12 patients with post-operative pain following removal of impacted lower third molars. 2 Significant analgesia after 600 mg aspirin occurred only at 45 min after administration, whereas significant analgesia after 1200 mg aspirin occurred from 45 to 240 min. The 1200 mg dose produced greater analgesia than the 600 mg dose and is to be recommended in clinical practice. 3 Plasma concentrations of salicylate and acetylsalicylate were measured after both doses. A significant correlation (rs = 0.876, P less than 0.01) was observed between analgesia and plasma salicylate concentration after 1200 mg aspirin.
Collapse
|
24
|
Matsumoto M, Kusunoki M, Uyama O, Fujisawa A, Matsuyama T, Yoneda S, Kimura K, Abe H. Platelet aggregation induced by arachidonic acid and thromboxane generation in patients with hypertension or cerebrovascular disease. PROSTAGLANDINS AND MEDICINE 1981; 7:553-62. [PMID: 7323212 DOI: 10.1016/0161-4630(81)90045-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
The aggregability of platelets to arachidonic acid (AA) was investigated in 26 control subjects, 40 patients with essential hypertension, 20 patients with ischemic cerebrovascular diseases (CVD) not taking aspirin and 11 patients with CVD taking aspirin. The aggregability of platelets was evaluated on the basis of threshold concentrations of AA to induce irreversible platelet aggregation. The enhanced sensitivity of platelets to AA was observed more frequently in hypertensives and/or CVD patients not taking aspirin than in the controls. The relationship between platelet aggregation induced by AA and thromboxane B2 (TXB2) formation from AA or prostaglandin H2 (PGH2) in platelets was also studied in the subjects taking or not taking aspirin. It was proposed that the assessment of platelet aggregability with AA could provide a tool for identifying a subgroup of patients who might substantially benefit from the secondary preventive treatment with aspirin or other anti-platelet drugs. The clinical usefulness of this aggregation test for the management of the patients taking aspirin was also discussed.
Collapse
|
25
|
Abstract
The bioavailability of aspirin gum relative to unbuffered aspirin tablets was determined in six normal volunteers. Twenty-four hours following the administration of two aspirin tablets, 91.2 +/- 1.7% (SE) of the 648-mg dose was recovered in the urine. The relative bioavailability of aspirin gum was 69.5 +/- 3.4% (SE), based on cumulative 4-hr urinary excretion of total salicylate after the chewing of three gum tablets for 15 min. The chewed gum was analyzed for total salicylate and contained an average of 37.8% of the administered dose. When added to the cumulative amount of total salicylate excreted in the urine at 24 hr after dosing, the salicylate contained in the chewed gum accounted for essentially 100% of the dose administered. Chewing aspirin gum for up to 30 min did not significantly (p greater than 0.05) reduce the amount of salicylate entrapped in the gum base when compared to chewing times of 5, 10, and 15 min. Based on the results of this study, four pieces of aspirin gum would be needed to provide the same amount of salicylate to the general circulation as two 324-mg aspirin tablets.
Collapse
|
26
|
Galante RN, Egoville JC, Visalli AJ, Patel DM. Simultaneous GLC analysis of aspirin and nonaspirin salicylates in pharmaceutical tablet formulations. J Pharm Sci 1981; 70:167-9. [PMID: 7205221 DOI: 10.1002/jps.2600700213] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
The analysis of aspirin and nonaspirin salicylates in buffered and plain tablet formulations employing nearly nonaqueous extraction is described. The results obtained compare favorably with those obtained from USP procedures. A simultaneous assay for aspirin and nonaspirin salicylates in buffered tablets involves the use of an acidified chromatographic siliceous earth column for the separation of the aspirin and nonaspirin salicylates from various buffers or antacids. The methods described here have definite advantages over USP XX procedures, and the buffered aspirin tablet procedures also is adaptable to aspirin formulations containing codeine, acetaminophen, propoxyphene, caffeine, and many antihistamines.
Collapse
|
27
|
Ebel S, Liedtke R, Missler B. [Determination of salicylamide in blood using direct injection HPLC]. Arch Pharm (Weinheim) 1980; 313:674-9. [PMID: 7416925 DOI: 10.1002/ardp.19803130804] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
28
|
Seegers JM, Olling M, Jager LP, Van Noordwijk J. Interactions of aspirin with acetaminophen and caffeine in rat stomach: pharmacokinetics of absorption and accumulation in gastric mucosa. J Pharm Sci 1980; 69:900-6. [PMID: 7400934 DOI: 10.1002/jps.2600690811] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
To study the pharmacokinetic interactions between aspirin (250 mg/kg) and simultaneously administered oral acetaminophen (125 mg/kg) or caffeine (50 mg/kg) in male rats, noninterfering GLC assays for these drugs were developed. Acetaminophen and caffeine both retarded the appearance of salicylate in plasma. During the elimination phase, acetaminophen enhanced plasms salicylate levels whereas caffeine did not. Aspirin reduced the plasms levels of both acetaminophen and caffeine during absorption and elimination. Regardless of whether the drugs had been administered separately or in combination, higher concentrations of salicylate, acetaminophen, and caffeine were found in the glandular part of the stomach compared to the nonglandular part (rumen). In both parts, the absorption of acetaminophen increased in the presence of aspirin. Simultaneous administration of aspirin with caffeine did not influence the absorption of either drug in the glandular and ruminal parts. The inhibitory action of acetaminophen and the potentiating action of caffeine on the erosive activity of aspirin are not due to any effects of these drugs on salicylate accumulation in glandular tissue.
Collapse
|
29
|
Lo LY, Bye A. Specific and sensitive method for the determination of aspirin and salicylic acid in plasma using reversed-phase high-performance liquid chromatography. JOURNAL OF CHROMATOGRAPHY 1980; 181:473-7. [PMID: 7391162 DOI: 10.1016/s0378-4347(00)81152-4] [Citation(s) in RCA: 39] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
30
|
Abstract
A nonsolvolytic (solid-state) acetylation of codeine phosphate in the presence of aspirin to yield acetylcodeine phosphate is reported. GLC assays for the simultaneous determination of aspirin and salicylic acid and codeine and acetylcodeine are described. The apparent heat of activation for codeine phosphate is estimated, and the possible reaction mechanisms are discussed.
Collapse
|
31
|
Wood SG, Al-Ani MR, Lawson A. GLC determination of purity of Schiff bases bakrine and saddamine. J Pharm Sci 1979; 68:374-6. [PMID: 423134 DOI: 10.1002/jps.2600680334] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
GLC methods were developed for the investigation of impurities in bakrine and saddamine. The method used for bakrine was unsuitable for saddamine since two possible saddamine impurities, benzylamine and salicylaldehyde, reacted very readily in solution to form saddamine, thus giving a false low value for the original concentration of these impurities. The method devised for saddamine involved silylation, which greatly reduced the possibility of saddamine formation from its precursors and also enabled the detection of another possible impurity, salicylic acid. The method described has an obvious application to the determination of other Schiff bases.
Collapse
|
32
|
de Boer AG, Gubbens-Stibbe JM, de Koning FH, Bosma A, Breimer DD. Assay of underivatized salicylamide in plasma, saliva and urine. JOURNAL OF CHROMATOGRAPHY 1979; 162:457-60. [PMID: 528613 DOI: 10.1016/s0378-4347(00)81536-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
33
|
Aspirin. ACTA ACUST UNITED AC 1979. [DOI: 10.1016/s0099-5428(08)60112-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/11/2023]
|
34
|
Koch PA, Schultz CA, Wills RJ, Hallquist SL, Welling PG. Influence of food and fluid ingestion on aspirin bioavailability. J Pharm Sci 1978; 67:1533-5. [PMID: 712586 DOI: 10.1002/jps.2600671110] [Citation(s) in RCA: 47] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
The influence of test meals and accompanying fluid volume on aspirin bioavailability from commercial tablets was determined following single oral doses to healthy male volunteers. Plasma aspirin and salicylate levels were determined simultaneously using a GLC end-point. Area analysis indicated that approximately 5--8% of absorbed drug entered the systemic circulation as unchanged aspirin in nonfasted subjects compared to 16--18% in fasted individuals. Food tended to reduce the appearance rate of aspirin into the circulation, resulting in lower and somewhat more sustained levels than with fasting. Plasma salicylate levels were not influenced markedly by the various treatments, although levels were higher in fasted than in nonfasted subjects during the 1st hr after dosing. After this time, fat pretreatment tended to produce higher levels than other treatments.
Collapse
|
35
|
Peng GW, Gadalla MA, Smith V, Peng A, Chiou WL. Simple and rapid high-pressure liquid chromatographic simultaneous determination of aspirin, salicylic acid, and salicyluric acid in plasma. J Pharm Sci 1978; 67:710-2. [PMID: 641818 DOI: 10.1002/jps.2600670540] [Citation(s) in RCA: 71] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
A rapid and sensitive high-pressure liquid chromatographic assay was developed for aspirin, salicylic acid, and salicyluric acid in plasma. The procedure involves the solvent extraction of these compounds from plasma and separation using a reversed-phase column eluted by acidified aqueous acetonitrile. Small quantitites of aspirin can be assayed directly in the presence of a large quantity of salicylic acid. The assay is also free from blank interference.
Collapse
|
36
|
Terweij-Groen CP, Vahilkamp T, Kraak JC. Rapid direct determination of trace amounts of salicylic acid in deproteinized serum by means of high-pressure liquid--liquid chromatography. JOURNAL OF CHROMATOGRAPHY 1978; 145:115-22. [PMID: 621236 DOI: 10.1016/s0378-4347(00)81673-4] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
A simple method for the quantitative analysis of salicylic acid in blood serum is described. A liquid--liquid chromatographic system, consisting of a long-chain aliphatic amine as the stationary phase and dilute aqueous perchloric acid as the mobile phase, enables the direct injection of deproteinized serum into the system. No change in the chromatographic properties of the system was noticed after 2000 injections of deproteinized serum. Quantitative analysis is possible using peak area or peak height measurements. The method has a high precision: relative standard deviations of 0.4% and 5% are found for samples containing 10 micrograms and 10 ng injected salicylic acid respectively. The detection limit is found to be about 1 ng slicylic acid, corresponding to 40 ppb salicylic acid in serum. Simultaneously administered drugs such as indomethacin, acetylsalicylic acid, caffeine and phenacetin, and metabolites of salicylic acid do not interfere with the analysis. The time course of the concentration of salicylic acid in serum is demonstrated after oral administration of 1 g sodium-salicylate. The phase system was also found to be suitable for the analysis of salicylic acid in urine.
Collapse
|
37
|
Abstract
A rapid gas-solid chromatographic method is reported for the direct analysis of salicylic acid in keratolytic plaster. The method requires no preseparation or derivatization and takes about 14 min. Since it requires only 2-7 mg of sample, it can determine the salicylic acid concentration in a particular area of plaster. The analyzing column is packed with porous polymer beads of 2,6-diphenyl-1,4-phenylene oxide. An automatic solid sampling system is used to connection with the gas chromatograph employing dual flame-ionization detectors. The average recovery of salicylic acid in synthetic samples containing 400-2700 microgram was 100.6 +/-1.6%. The average correlation coefficient of the peak area against the standard was +0.9995 +/- 0.0003 for samples in the 300-3000-microgram range.
Collapse
|
38
|
Mayersohn M, Chow MS, Kostenbauder HB, Rowland M. Aspirin. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION 1977; 17:107-12. [PMID: 845363 DOI: 10.1016/s0003-0465(16)34247-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
39
|
Ali SL. Application of gas-liquid chromatography and high-performance liquid chromatography to the analysis of trace amounts of salicylic acid, acetylsalicylic anhydride and acetylsalicylsalicylic acid in aspirin samples and aspirin formulations. J Chromatogr A 1976; 126:651-63. [PMID: 977701 DOI: 10.1016/s0021-9673(01)84109-1] [Citation(s) in RCA: 38] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
The gas-liquid chromatographic (GLC) determination of salicylic acid (SA) in 12 commercial acetylsalicylic acid (aspirin, ASA) samples and 12 ASA formulations is reported. The GLC determination of SA as an impurity in ASA, utilising methylation with methyl iodide in the presence of potassium carbonate, requires a column chromatographic separation of SA prior to derivatization. Trace amounts of SA in ASA have also been determined by high-performance liquid chromatography (HPLC) on a Sil-X-I adsorption column using light petroleum-ethyl acetate-acetic acid as the mobile phase. Acetylsalicylic anhydride (ASN) and acetylsalicylsalicylic acid (ASSA) were determined by HPLC on a reversed-phase C18 column with water-methanol mixtures as the mobile phase. GLC was also applied to the determination of ASN as an impurity in ASA formulations.
Collapse
|